President Donald Trump has, across two administrations, sought to lower drug prices for Americans, most recently with executive order “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Margherita Colangelo explains why his order is unlikely to accomplish its goal.
Skewed incentives and the distribution of resources toward corporations have undermined the integrity of scientific research and contributed to the public’s distrust in expertise....
The European Commission has struggled to tackle excessive prices in Europe, despite evidence of how they arise in relation to market power. Aline Blankertz, Todd Davies, Justine Haekens, and Nicholas Shaxson argue that adopting accounting and financial analysis as part of its toolkit can enable the Commission to understand and act when firms are exploiting their market power.
Reed Showalter argues that the suggestion that antitrust can be ringfenced from democracy or the democratic process is erroneous. Antitrust is fundamentally a body...
Yunsieg P. Kim argues that economic regulation, including antitrust, can only be democratic if it is the choice of well-informed citizens.
This article is part...
Erik Peinert explores the paradoxical relationship between economic concentration and democracy, where economic concentration compromises the democratic process and democratic backsliding also gains momentum by taking advantage of concentrated market actors, whose political power is now impotent, to capture civil society.
Gerhard Schick discusses the CumEx and CumCum share-trading scandals that cost German taxpayers billions of euros over the course of several decades and the failures in political and social institutions that allowed these scandals to persist for so long.
Former Federal Trade Commissioner and Consumer Financial Protection Bureau Director Rohit Chopra writes that as the federal government circumvents the rule of law by pardoning corporate infractions and crimes in exchange for political favors, individual states, citizens, and businesses will need to pursue private actions against corporate wrongdoing.
Max von Thun and Claire Lavin argue that the European Commission must revise its merger guidelines to emphasize how competition policy can protect goals beyond prices, including innovation, security, and democracy. This will create a more prosperous European Union.